Análisis opcionales del producto
Con tu permiso, usamos análisis limitados y respetuosos con la privacidad para entender qué recorridos de investigación funcionan. No usamos rastreadores publicitarios ni grabación de sesiones. Puedes cambiar esta opción en Preferencias. Lee la Política de privacidad.
Berkshire Hathaway Inc. Class B's published Sell conclusion compares the analysis-date price with fair value and potential value. Read the full report for assumptions, evidence, and material risks.
| Market cap | $1.09T | |
|---|---|---|
| Revenue (ttm) | 384.7B | |
| Net income (ttm) | 85.8B | |
| EPS (ttm) | $39.8 | |
| Shares out | 2.1B | |
| P/E (trailing) | 13.6x | |
| P/E (forward) | 23.0x | |
| Volume | 2,100,315 | |
| Beta | 0.59 |
Recent price action with selectable time range.
| Item | P1 | P2 | P3 | P4 | P5 | Trend |
|---|---|---|---|---|---|---|
| Period | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | Trend |
| Revenue | $191.25B | $207.77B | $254.91B | $249.71B | $247.24B | +6.6% |
| Gross profit | $207.84B | $0 | $0 | $0 | $0 | — |
| Operating income | $199.30B | $-26.15B | $125.17B | $115.58B | $87.53B | -18.6% |
| Net income | $89.94B | $-22.76B | $96.22B | $89.00B | $66.97B | -7.1% |
| EPS (diluted) | $39.68 | $-10.33 | $44.27 | $41.27 | $31.04 | -6.0% |
| EBITDA | $210.02B | $-80.03B | $214.55B | $183.73B | $153.83B | -7.5% |
| R&D | — | — | — | — | — | — |
| SG&A | — | $25.06B | $31.50B | $32.71B | $37.42B | +14.3% |
Recent company headlines from major financial publishers.
Under the Base scenario, assigned a 55.0% probability, intrinsic value is estimated at $325.94, implying an expected return of -36.1% from $509.77. This path assumes normalized underwriting profitability, steady freight and energy volume, and gradual capital reinvestment. Disconfirmation would occur if underwriting margins deteriorate significantly or if interest rate cuts accelerate float yield decline before FY2027.
Under the Bull scenario, carrying a 20.0% probability, intrinsic value reaches Potential value of $383.68, reflecting an expected return of -24.7% compared to $509.77. This outcome requires prolonged commercial insurance rate hardening, accelerated capital deployment of liquidity into higher-yielding operating acquisitions, and resolution of utility liabilities without significant equity impairment.
| Ke ↓ / g → | 1.5% | 2.0% | 2.5% | 3.0% | 3.5% |
|---|---|---|---|---|---|
| 5.7% | $353 | $353 | $353 | $353 | $353 |
| 6.7% | $339 | $339 | $339 | $339 | $339 |
| 7.7% | $326 | $326 | $326 | $326 | $326 |
| 8.7% | $313 | $313 | $313 | $313 | $313 |
| 9.7% | $301 | $301 | $301 | $301 | $301 |
Upcoming earnings date and setup when available.
La calificación que llevaba la edición de análisis publicada cada mes. Una calificación compara el precio en la fecha del análisis con el valor razonable; no es un registro de si la valoración acertó.
| Año | ene | feb | mar | abr | may | jun | jul | ago | sept | oct | nov | dic |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 |